MedPath

the Effect of Exercise and Oral Supplement Intervention in Sarcopenia Markers in Hemodialysis Patients

Not Applicable
Conditions
Sarcopenia
Interventions
Other: 3 hours combined intervention ( Exercise and nutrition)
Other: 1 hour combined intervention ( Exercise and nutrition)
Dietary Supplement: Nutrition intervention
Registration Number
NCT05809219
Lead Sponsor
China Medical University Hospital
Brief Summary

Objective: To assess the effect of different post-exercise oral nutritional supplement intake timing on sarcopenia indicators in hemodialysis patients.

Study Design: 24-weeks Randomized Control Trial (RCT), includes 12-wk intervention period and 12-week follow up period.

Setting \& Participants: Maintenance hemodialysis patients who were older than 20 years old meet sarcopenia diagnosis criteria.

Intervention: Group A: During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement in 1 to 2 hours after exercise program. Group B: Participants have the same exercise program and oral supplement as Group A. However, they take oral supplement in 2.5-4 hours after exercise program. Group C: Participants only take oral supplement. Control group: Participants maintain usual diet and physical activity without any intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Hemodialysis treatment longer than 3 months
  • Hemodialysis treatment 3 times treatment per weeks
  • Kt/V≥1.2 or URR≥65%
  • Taking foods by oral
  • Meeting the criteria of sarcopenia.
Read More
Exclusion Criteria
  • Soy allergy
  • Amputation
  • Significantly edema
  • Receiving palliative care
  • Severe angina
  • Unstable arrhythmias
  • Severe infection
  • Heart failure (class 4 of New York Heart Association scale)
  • Central venous catheter or femoral arteriovenous fistula
  • Pacemaker
  • Pregnancy
  • Severe paleness
  • Severe difficulty breathing
  • Chest pain
  • Hospitalization 3 months before recruited in this study
  • Oral supplement intolerance diagnosed by the doctor or dietitian
  • Bone injury/nerve damage/cognition impairment affecting physical activity intervention
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
3 hours combined intervention ( Exercise and nutrition)3 hours combined intervention ( Exercise and nutrition)The only one different between "1 hour combined intervention" and this intervention is the time interval between exercise and nutrition. The time interval of "1 hour combined intervention" is 1 to 2 hour, and this intervention is 2.5-4 hours. Other procedure is totally the same.
1 hour combined intervention ( Exercise and nutrition)1 hour combined intervention ( Exercise and nutrition)During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement (103 kcal and 8.4 g of protein) in 1 to 2 hours after exercise program.
Nutrition interventionNutrition interventionParticipants only take oral supplement. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".
Primary Outcome Measures
NameTimeMethod
Appendicular skeletal muscle massChange from baseline appendicular skeletal muscle mass at 6 months

The weight of appendicular skeletal muscle mass. This is one of the sarcopenia indicator.

Muscle strengthChange from baseline muscle strength at 6 months

The measurement of handgrip strength. This is one of the sarcopenia indicator.

Physical performanceChange from baseline physical performance at 6 months

Measuring whether the of 6-metre walk is less than 1.0 m/s or not. This is one of the sarcopenia indicator.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

China Medical University Hospital

🇨🇳

Taichung City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath